Syntagon to attend the 2011 Biotech Outsourcing Strategies (BOS) show on September 20th
Syntagon will be attending the 2011 Biotech Outsourcing Strategies (BOS) show at the Royal College of Physicians in London on September 20th.
BOS 2011 is the leading outsourcing-focused partnering event for the biotech, pharmaceutical, and the contract services industry. The show is also important to R&D professionals with an outsourcing role in discovery, CMC and clinical operations.
Syntagon to exhibit at the 2011 Chem Outsourcing Show in New Jersey, USA
Syntagon will exhibit at the 2011 Chem Outsourcing Show on September 12th, 2011. With over 100 speakers, the ChemOutsourcing show includes speakers, exhibitors, and attendees from the pharmaceutical and biotech industry, including a number of small molecule biotechnology company chemists.
Make sure to stop by Booth #102, drop off your business card in our fish bowl for a chance to win a free iPad and chat with Syntagon to see what we have to offer.
Metal impurities in drug substances
Currently, the International Conference on Harmonisation (ICH) Q3A guidelines classifies impurities into three main areas: organic, inorganic and residual solvents. With a new guideline, USP outlines procedures and detection techniques for improved sensitivity and selectivity of element impurities as well as new advice on sample preparation and validation of analytical methods. Syntagon Case Studies
Syntagon has gained a huge amount of experience in measuring, monitoring and, if needed, reducing a wide variety of metal impurities during the course of many GMP syntheses. By continually monitoring changes in the regulations, Syntagon ensures specifications are met and regulatory compliance is guaranteed.
Syntagon welcomes the introduction of the new ICH Q3A guidelines, which will cover the acceptable limits of elemental impurities and the procedures by which they will be measured.